Characteristics And Outcomes Of Metastatic Sdhb And Sporadic Pheochromocytoma/Paraganglioma: An National Institutes Of Health Study-Reference-Cited by-同舟云学术

Characteristics And Outcomes Of Metastatic Sdhb And Sporadic Pheochromocytoma/Paraganglioma: An National Institutes Of Health Study

Published:2016-03 Issue:3 Volume:22 Page:302-314
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Turkova Hana,Prodanov Tamara,Maly Marek,Martucci Victoria,Adams Karen,Widimsky Jiri,Chen Clara C.,Ling Alexander,Kebebew Electron,Stratakis Constantine A.,Fojo Tito,Pacak Karel

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference56 articles.

1. Pathology and Genetics of Tumours of Endocrine Organs;DeLellis,2004

2. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis;van Nederveen;Lancet Oncol,2009

3. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes;Gimenez-Roqueplo;Horm Metab Res,2012

4. Novel hereditary forms of pheochromocytomas and paragangliomas;Dahia;Front Horm Res,2013

5. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma;Timmers;Endocr Relat Cancer,2009

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients;Frontiers in Endocrinology;2024-08-21

2. Diagnosis and management of patients with pheochromocytoma/paraganglioma: Consensus of experts of the Russian Medical Society for Arterial Hypertension and the Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors;Terapevticheskii arkhiv;2024-07-30

3. CT-Based Radiomics Analysis of Different Machine Learning Models for Discriminating the Risk Stratification of Pheochromocytoma and Paraganglioma: A Multicenter Study;Academic Radiology;2024-07

4. Prevalence and prognosis of hypoxia‐inducible factor‐2α (HIF‐2α) pathway gene mutations across advanced solid tumors;Cancer Medicine;2024-06

5. EPAS1-related pheochromocytoma/paraganglioma;Endocrine-Related Cancer;2024-05-20